Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Paclitaxel in Elderly Patients With Metastatic or Recurrent Unresectable Non-Small Cell Lung Cancer
NCT00005059Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2000
- Primary completion
- Jul 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Started Jan 2000; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005059.